Results 181 to 190 of about 158,415 (307)

Nanoparticle-boosted myeloid-derived suppressor cell therapy for immune reprogramming in multiple sclerosis. [PDF]

Sci Adv
Zhang E, Algarni H, Zhang L, Chao CJ, He S, Upadhye A, Bao Q, Jung D, Srivastava S, Udofa E, Phan P, Nikolic DS, Lee SS, Rehman J, Zhao Z.   +14 more
europepmc   +1 more source

Identifying Cytokine Motif‐Containing, Immunomodulatory Bacterial Proteins in Human Gut Microbiome

Advanced Science, EarlyView.
By building and constructing HMM (Upper left, blue), the authors identify CMCPs in bacteria genomes and CRC related metagenomes and enriched CRC‐related CMCPs (Upper right, blue). They analyze sequence and structural similarity of hits (Lower left, green), test function with engineered EcN delivered to tumors in a mouse tumor model (Lower right, pink ...
Ziyu Wang, Siqi Guo, Jing Li, Qianqian Huang, Jing Ning, Binbin Xia, Xun Lv, Xiang Liu, Zeyu Gao, Jine Li, Longchao Liu, Moshi Song, Jun Wang   +12 more
wiley   +1 more source

Myeloid-Derived Suppressor Cells [PDF]

, 2015
openaire   +1 more source

<i>CMTM8</i> variants influence BNT162b2 COVID-19 vaccination response by regulating granulocytic/polymorphonuclear myeloid-derived suppressor cell activity. [PDF]

Front Immunol
Testori A, Mulas A, Marongiu M, Orrù V, Lobina M, Piras MG, Lutzu E, Curreli N, Politi C, Mobrici M, Iervasi G, Corda D, De Felice M, Testa A, Devoto M, Steri M, Fiorillo E, SerGenCovid-19 Investigators.   +17 more
europepmc   +1 more source

Targeting m6A Reader YTHDF1 Enhances Antitumor Immunity and Potentiates Anti‐PD‐L1 Efficacy in Intrahepatic Cholangiocarcinoma

Advanced Science, EarlyView.
The m6A reader YTHDF1 drives intrahepatic cholangiocarcinoma (ICC) progression by remodeling the tumor immune microenvironment. YTHDF1 promotes MDSC recruitment via activation of m6A‐FOSL2‐CXCL6/CXCR2 axis, thereby suppressing CD8+ T cell infiltration and function.
Li Luo, Ziqin Liu, Zimin Song, Dong Zhang, Cong Liang, Fei Fang, Kai Lei, Lina Wang, Weikang Chen, Shunli Shen, Ming Kuang, Xiaoxing Li, Jun Yu, Shiyan Wang, Lixia Xu   +14 more
wiley   +1 more source

HIV vaccines: Unmasking myeloid derived suppressor cells

EBioMedicine, 2020
William R. Green, Megan A. O'Connor
openaire   +3 more sources

Nociceptive Neurons Promote Myeloid-Derived Suppressor Cell Mobilization to Alleviate Post-Stroke Neuroinflammation. [PDF]

Theranostics
Cai L, Zhou J, Cao X, Huang H, Xie Q, Chu H, Chen G, Jin L, Mao Z, Yan F.   +9 more
europepmc   +1 more source

Myeloid-Derived Suppressor-Cell Dynamics Control Outcomes in the Metastatic Niche. [PDF]

Cancer Immunol Res, 2023
Kreger J, Roussos Torres ET, MacLean AL.
europepmc   +1 more source

Macrophage Extracellular Traps in Immunity and Cancer

Advanced Science, EarlyView.
As a macrophage‐mediated innate defense mechanism, the dysregulated release of METs drives chronic inflammation and influences tumor progression. Furthermore, METs exhibit a functional duality within the tumor microenvironment, capable of both promoting and suppressing tumor development.
Junyao Li, Eugenie Nepovimova, Adam Grundel, Lukas Peter, Qinghua Wu, Kamil Kuca   +5 more
wiley   +1 more source

Characterizing the Emergence of Myeloid-Derived Suppressor Cell Subsets in a Murine Model of Pulmonary Fibrosis. [PDF]

FASEB J
Vedder N, Gercke P, Lautenschlager N, Brunn T, Lange T, Schieb J, Vetter C, van Geffen C, Kolahian S.   +8 more
europepmc   +1 more source